Penn Center for AIDS Research

Ezekiel J. Emanuel

faculty photo
Diane v.S. Levy and Robert M. Levy University Professor
Penn Integrates Knowledge Professor, University of Pennsylvania
Professor, The Wharton School, University of Pennsylvania
Vice Provost for Global Initiatives , University of Pennsylvania
Senior Fellow , Leonard Davis Institute, University of Pennsylvania
Co-Director Health Transformation Institute, Perelman School of Medicine
Department: Medical Ethics and Health Policy

Contact information
122 College Hall
Philadelphia, PA 19104-6303
Office: 215-898-7226
Fax: 215-898-6567
BA (Chemistry)
Amherst College, 1979.
MSC (Biochemistry)
Exeter College, Oxford University, 1981.
MD (Internal Medicine)
Harvard Medical School, 1988.
PhD (Political Philosophy)
Harvard University, 1989.
Post-Graduate Training
Fellow in Ethics and the Professions, Kennedy School of Government Harvard University Cambridge, Massachusetts, 1987-1988.
Intern in Medicine, Beth Israel Hospital Boston, Massachusetts, 1988-1989.
Resident in Medicine, Beth Israel Hospital Boston, Massachusetts, 1989-1990.
Fellow in Medical Oncology, Dana-Farber Cancer Institute Boston, Massachusetts , 1990-1992.
Clinical Fellow in Medicine, Harvard Medical School Boston, Massachusetts , 1990-1992.
Diplomate in Internal Medicine (#140009) American Board of Internal Medicine, 1991.
Diplomate in Medical Oncology (#140009) American Board of Internal Medicine, 1994.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Emanuel EJ, Osterholm M, Gounder CR: A National Strategy for the "New Normal" of Life With COVID. JAMA 327: 211-212, Jan 2022.

Borio LL, Bright RA, Emanuel EJ: A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics. JAMA 327: 215-216, Jan 2022.

Michaels D, Emanuel EJ, Bright RA: A National Strategy for COVID-19: Testing, Surveillance, and Mitigation Strategies. JAMA 327: 213-214, Jan 2022.

Emanuel EJ, Fabre C, Herzog L, Norheim OF, Persad G, Schaefer GO, Tan KC.: Obligations in a global health emergency - Authors' reply. Lancet 398: 2072, Dec 2021.

Emanuel EJ, Diana A: Considering the Future of Price Transparency Initiatives-Information Alone Is Not Sufficient. JAMA Netw Open 4(12): e2137566, Dec 2021.

Frank RG, Emanuel EJ.: Paying for Cancer Drugs That Prove Their Benefit. JAMA 326: 1579-1580, Oct 2021.

Emanuel EJ.: A Middle Ground for Accelerated Drug Approval-Lessons From Aducanumab. JAMA 326: 1367-1368, Oct 2021.

Emanuel EJ, Buchanan A, Chan SY, Fabre C, Halliday D, Heath J, Herzog L, Leland RJ, McCoy MS, Norheim OF, Saenz C, Schaefer GO, Tan KC, Wellman CH, Wolff J, Persad G.: What are the obligations of pharmaceutical companies in a global health emergency? Lancet 398: 1015-1020, Sep 2021.

Schaefer GO, Leland RJ, Emanuel EJ.: Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations. JAMA 326: 903-904, Sep 2021.

Wagner CE, Saad-Roy CM, Morris SE, Baker RE, Mina MJ, Farrar J, Holmes EC, Pybus OG, Graham AL, Emanuel EJ, Levin SA, Metcalf CJE, Grenfell BT.: Vaccine nationalism and the dynamics and control of SARS-CoV-2. Science 373: eabj7364, Sep 2021.

back to top
Last updated: 03/08/2022
The Trustees of the University of Pennsylvania